ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
9 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
9
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
TheAnalyst007
|
2.8K |
682K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
2.8K
|
682K
|
5
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
7 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
7
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
1
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
3
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
5
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
4 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
4
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
5
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
5
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
3
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
TheAnalyst007
|
534 |
149K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
534
|
149K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
TheAnalyst007
|
534 |
149K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
534
|
149K
|
1
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: March 2024 Quarterly Activities Report and Appendix 4C
|
|
TheAnalyst007
|
24 |
8.5K |
13 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
24
|
8.5K
|
13
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
5
|
|
ASX - By Stock
|
BOT |
Re:
Ann: March 2024 Quarterly Activities Report and Appendix 4C
|
|
TheAnalyst007
|
24 |
8.5K |
9 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
24
|
8.5K
|
9
|
|
Political Debate
|
|
Re:
I'm With Israel
|
|
TheAnalyst007
|
308 |
30K |
6 |
30/04/24 |
30/04/24 |
Political Debate
|
308
|
30K
|
6
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
TheAnalyst007
|
42K |
20M |
6 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
42K
|
20M
|
6
|
|
ASX - By Stock
|
DRO |
Re:
Ann: SPP Early Closure Due To Excess Demand
|
|
TheAnalyst007
|
21 |
7.9K |
4 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
21
|
7.9K
|
4
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Becoming a substantial holder
|
|
TheAnalyst007
|
13 |
3.0K |
4 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
13
|
3.0K
|
4
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
TheAnalyst007
|
42K |
20M |
33 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
42K
|
20M
|
33
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Becoming a substantial holder
|
|
TheAnalyst007
|
13 |
3.0K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
13
|
3.0K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Ann: March 2024 Quarterly Activities Report and Appendix 4C
|
|
TheAnalyst007
|
24 |
8.5K |
14 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
24
|
8.5K
|
14
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
TheAnalyst007
|
71 |
20K |
7 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
71
|
20K
|
7
|
|
ASX - By Stock
|
PLS |
Re:
Good News & Bad News
|
|
TheAnalyst007
|
42K |
20M |
10 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
42K
|
20M
|
10
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
TheAnalyst007
|
71 |
20K |
9 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
71
|
20K
|
9
|
|
ASX - Day Trading
|
|
Re:
Morning Trading April 30
|
|
TheAnalyst007
|
221 |
32K |
2 |
30/04/24 |
30/04/24 |
ASX - Day Trading
|
221
|
32K
|
2
|
|
ASX - By Stock
|
DRO |
Re:
Ann: SPP Early Closure Due To Excess Demand
|
|
TheAnalyst007
|
21 |
7.9K |
8 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
21
|
7.9K
|
8
|
|
ASX - Day Trading
|
|
Re:
Morning Trading April 30
|
|
TheAnalyst007
|
221 |
32K |
3 |
30/04/24 |
30/04/24 |
ASX - Day Trading
|
221
|
32K
|
3
|
|
ASX - By Stock
|
DRO |
Re:
Ann: SPP Early Closure Due To Excess Demand
|
|
TheAnalyst007
|
21 |
7.9K |
3 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
21
|
7.9K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
TheAnalyst007
|
71 |
20K |
8 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
71
|
20K
|
8
|
|
ASX - By Stock
|
EYE |
Re:
2RT: A Groundbreaking Treatment for AMD (Major Partnership Deal Imminent)
|
|
TheAnalyst007
|
81 |
23K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
81
|
23K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Complete response with Cu-67 SAR-bisPSMA
|
|
TheAnalyst007
|
71 |
20K |
10 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
71
|
20K
|
10
|
|
ASX - By Stock
|
EYE |
Re:
2RT: A Groundbreaking Treatment for AMD (Major Partnership Deal Imminent)
|
|
TheAnalyst007
|
81 |
23K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
81
|
23K
|
5
|
|
ASX - By Stock
|
EYE |
Re:
2RT: A Groundbreaking Treatment for AMD (Major Partnership Deal Imminent)
|
|
TheAnalyst007
|
81 |
23K |
5 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
81
|
23K
|
5
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
TheAnalyst007
|
843 |
288K |
4 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
843
|
288K
|
4
|
|
ASX - By Stock
|
ZIP |
Re:
$2 PARTY
|
|
TheAnalyst007
|
7.3K |
1.3M |
5 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
7.3K
|
1.3M
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
TheAnalyst007
|
153 |
58K |
4 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
153
|
58K
|
4
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
TheAnalyst007
|
2.8K |
682K |
10 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
2.8K
|
682K
|
10
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
TheAnalyst007
|
2.8K |
682K |
2 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
2.8K
|
682K
|
2
|
|
World Politics
|
|
Re:
ISRAEL MUST BE STOPPED NOW !
|
|
TheAnalyst007
|
7.6K |
755K |
3 |
29/04/24 |
29/04/24 |
World Politics
|
7.6K
|
755K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Ann: SCENESSE European Orphan Drug Designation for XP
|
|
TheAnalyst007
|
11 |
4.1K |
5 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
11
|
4.1K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
4 billion market cap breached
|
|
TheAnalyst007
|
15 |
7.4K |
6 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
15
|
7.4K
|
6
|
|
ASX - By Stock
|
VEE |
Re:
Ann: Acceptance of Sharrow Propeller Performance Results
|
|
TheAnalyst007
|
3 |
1.5K |
1 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
3
|
1.5K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Ann: SCENESSE European Orphan Drug Designation for XP
|
|
TheAnalyst007
|
11 |
4.1K |
13 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
11
|
4.1K
|
13
|
|
ASX - By Stock
|
DRO |
Re:
DRO - Chart and TA.
|
|
TheAnalyst007
|
1.0K |
371K |
4 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
1.0K
|
371K
|
4
|
|
ASX - By Stock
|
WA1 |
Re:
General discussion
|
|
TheAnalyst007
|
7.1K |
1.8M |
4 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
7.1K
|
1.8M
|
4
|
|
ASX - By Stock
|
DRO |
Re:
DRO - Chart and TA.
|
|
TheAnalyst007
|
1.0K |
371K |
3 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
1.0K
|
371K
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Sofdra - Post approval royalties, costs and earnings
|
|
TheAnalyst007
|
31 |
10K |
14 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
31
|
10K
|
14
|
|